Mufg Americas Holdings Corp Edwards Lifesciences Corp Transaction History

Mufg Americas Holdings Corp

$0
Q3 2023

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	BUY	$82.37 - $107.29 $1.46 Million - $1.9 Million	17,751 Added 30.46%	76,029 $6.28 Million
Q3 2022 Oct 31, 2022	BUY	$82.37 - $107.29 $1.46 Million - $1.9 Million	17,751 Added 30.46%	76,029 $6.28 Million
Q2 2022 Dec 01, 2022	BUY	$86.5 - $128.27 $685,253 - $1.02 Million	7,922 Added 15.73%	58,278 $5.54 Million
Q2 2022 Aug 02, 2022	BUY	$86.5 - $128.27 $685,253 - $1.02 Million	7,922 Added 15.73%	58,278 $5.54 Million
Q1 2022 Dec 01, 2022	BUY	$101.96 - $128.34 $1.49 Million - $1.88 Million	14,643 Added 41.0%	50,356 $5.93 Million
Q1 2022 May 06, 2022	BUY	$101.96 - $128.34 $1.49 Million - $1.88 Million	14,643 Added 41.0%	50,356 $5.93 Million
Q4 2021 Dec 01, 2022	BUY	$106.37 - $130.68 $281,774 - $346,171	2,649 Added 8.01%	35,713 $4.63 Million
Q4 2021 Feb 09, 2022	BUY	$106.37 - $130.68 $281,774 - $346,171	2,649 Added 8.01%	35,713 $4.63 Million
Q3 2021 Dec 01, 2022	BUY	$102.91 - $122.75 $94,574 - $112,807	919 Added 2.86%	33,064 $3.74 Million
Q3 2021 Nov 05, 2021	BUY	$102.91 - $122.75 $94,574 - $112,807	919 Added 2.86%	33,064 $3.74 Million
Q2 2021 Dec 01, 2022	BUY	$83.84 - $104.76 $359,673 - $449,420	4,290 Added 15.4%	32,145 $3.33 Million
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $359,673 - $449,420	4,290 Added 15.4%	32,145 $3.33 Million
Q1 2021 Dec 01, 2022	SELL	$78.68 - $90.67 $13,926 - $16,048	-177 Reduced 0.63%	27,855 $2.33 Million
Q1 2021 Apr 30, 2021	SELL	$78.68 - $90.67 $13,926 - $16,048	-177 Reduced 0.63%	27,855 $2.33 Million
Q4 2020 Dec 01, 2022	BUY	$71.69 - $91.23 $143,021 - $182,003	1,995 Added 7.66%	28,032 $2.56 Million
Q4 2020 Feb 03, 2021	BUY	$71.69 - $91.23 $143,021 - $182,003	1,995 Added 7.66%	28,032 $2.56 Million
Q3 2020 Dec 01, 2022	SELL	$67.19 - $87.44 $557,475 - $725,489	-8,297 Reduced 24.17%	26,037 $2.08 Million
Q3 2020 Nov 03, 2020	SELL	$67.19 - $87.44 $557,475 - $725,489	-8,297 Reduced 24.17%	26,037 $2.08 Million
Q2 2020 Dec 01, 2022	SELL	$57.54 - $76.95 $2.4 Million - $3.21 Million	-41,695 Reduced 54.84%	34,334 $2.37 Million
Q2 2020 Aug 06, 2020	BUY	$57.54 - $76.95 $1.33 Million - $1.78 Million	23,134 Added 206.55%	34,334 $2.37 Million
Q1 2020 Apr 24, 2020	SELL	$52.41 - $81.0 $56,078 - $86,670	-1,070 Reduced 8.72%	11,200 $2.11 Million
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $131,426 - $150,470	1,833 Added 17.56%	12,270 $2.86 Million
Q3 2019 Nov 06, 2019	BUY	$61.55 - $75.43 $140,026 - $171,603	2,275 Added 27.87%	10,437 $2.3 Million
Q2 2019 Aug 09, 2019	SELL	$55.74 - $64.41 $9,029 - $10,434	-162 Reduced 1.95%	8,162 $1.51 Million
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $4,453 - $5,956	-93 Reduced 1.1%	8,324 $1.59 Million
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $43,718 - $53,637	942 Added 12.6%	8,417 $429,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $39,530 - $50,195	865 Added 13.09%	7,475 $0
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $227,149 - $274,506	5,351 Added 425.02%	6,610 $0
Q1 2018 May 07, 2018	SELL	$37.19 - $47.45 $138,644 - $176,893	-3,728 Reduced 74.75%	1,259 $176,000
Q4 2017 Feb 08, 2018	SELL	$33.79 - $39.39 $5,879 - $6,853	-174 Reduced 3.37%	4,987 $0
Q3 2017 Nov 13, 2017	SELL	$36.29 - $38.83 $238,134 - $254,802	-6,562 Reduced 55.98%	5,161 $0
Q2 2017 Aug 07, 2017	BUY	N/A	11,723	11,723 $0

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Account